About the Glucocorticoids Impact Working Group

Glucocorticoids (GC), more commonly known as steroids, are used to treat many inflammatory diseases. The GC Impact Group studies the good and bad effects of GCs. Side effects, or adverse effects, of GCs are common. Some are easily measured and can usually be controlled such as high blood pressure and high blood sugar levels. Some are harder to control such as weight gain, osteoporosis (bone thinning) and cataracts. Effects such as mood and sleep disturbance, easy bruising and body shape changes are harder to measure. Certain effects are ‘events’, which are less common such as infections and fractures, whilst others are common ‘experiences’ that have variable effects such as weight gain, skin changes and sleep disturbance.

Another difficulty is knowing whether it is the GC, another medication used at the same time or the disease being treated leading to these effects is often difficult to work out. It is also not known which effects are most important and concerning to patients.

susan goodman

Susan Goodman

Co-Chair

catherine hill

Catherine Hill

Co-Chair

sarah mackie

Sarah Mackie

Co-Chair

Robson

Joanna Robson

Co-Chair

Screen Shot 2021-10-12 at 8.21.22 AM

Suellen Lyne

Fellow

joanna tieu

Joanna Tieu

Fellow

Screen Shot 2021-10-04 at 2.42.02 PM

Kevin Yip

Fellow

Pam Richards

Pam Richards

Patient Research Partner

Glucocorticoid Impact Whiteboard Overview

Glucocorticoid Impact Plenary Video

OMERACT Endorsed Core Domain Set for Glucocorticoid Impact

GC cds

Working Group Members:

Catherine Hill
Susan Goodman
Sarah Mackie
Joanna Robson
Pamela Richards
Suellen Lyne
Kevin Yip
Joanna Tieu
Jonathan Cheah
Rachel Black
Jas Singh
Susan Bridgewater
Robin Christensen
Elizabeth Hoon
Carlee Ruediger
Karima Becetti
Nilasha Ghosh
Chengappa Kavidachanda

Scroll to Top